US2019350953A1PendingUtilityA1
Composition for promoting increase in androgen
Assignee: KOBAYASHI PHARMACEUTICAL CO LTDPriority: Dec 28, 2016Filed: Dec 22, 2017Published: Nov 21, 2019
Est. expiryDec 28, 2036(~10.4 yrs left)· nominal 20-yr term from priority
A61K 31/704A61K 36/258A23L 33/10A23L 33/105A61P 5/26A23K 20/10
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An object of the present invention is to provide a composition for stimulating an increase in an androgen. The composition for stimulating an increase in an androgen contains compound K. The composition for stimulating an increase in an androgen contains a fermentation product and/or enzymatically degraded product of ginseng as an active ingredient.
Claims
exact text as granted — not AI-modified1 . A composition for stimulating an increase in an androgen, the composition comprising compound K.
2 . A composition for stimulating an increase in an androgen, the composition comprising a fermentation product and/or enzymatically degraded product of ginseng as an active ingredient.
3 . The composition according to claim 1 , wherein the androgen is testosterone.
4 . The composition according to claim 1 , wherein the compound K is present in an amount of 0.05 wt % or more in the composition.
5 . The composition according to claim 1 , wherein ginsenoside Rb1 is present in an amount of 10 wt % or less in the composition.
6 . The composition according to claim 2 , wherein the fermentation product is a microbial fermentation product of ginseng.
7 . The composition according to claim 2 , wherein the enzymatically degraded product is a glycosidase hydrolysis product of ginseng.
8 . The composition according to claim 1 , wherein the compound K is present in an amount of 0.12 to 160 mg/60 kg body weight for a daily intake.
9 . The composition according to claim 2 , wherein the fermentation product and/or enzymatically degraded product of ginseng is present in an amount of 19.2 to 24000 mg/60 kg body weight for a daily intake.
10 . The composition according to claim 1 , which is a food composition, a pharmaceutical composition, or a feed composition.
11 . The composition according to claim 1 , for use for a purpose of improving a symptom due to decreased androgen levels.
12 . The composition according to claim 2 , wherein the androgen is testosterone.
13 . The composition according to claim 2 , wherein the compound K is present in an amount of 0.05 wt % or more in the composition.
14 . The composition according to claim 2 , wherein ginsenoside Rb1 is present in an amount of 10 wt % or less in the composition.
15 . The composition according to claim 3 , wherein the fermentation product is a microbial fermentation product of ginseng.
16 . The composition according to claim 3 , wherein the enzymatically degraded product is a glycosidase hydrolysis product of ginseng.
17 . The composition according to claim 2 , wherein the compound K is present in an amount of 0.12 to 160 mg/60 kg body weight for a daily intake.
18 . The composition according to claim 3 , wherein the fermentation product and/or enzymatically degraded product of ginseng is present in an amount of 19.2 to 24000 mg/60 kg body weight for a daily intake.
19 . The composition according to claim 2 , which is a food composition, a pharmaceutical composition, or a feed composition.
20 . The composition according to claim 2 , for use for a purpose of improving a symptom due to decreased androgen levels.Join the waitlist — get patent alerts
Track US2019350953A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.